ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RAD)

0,02
0,001
(5,26%)
Fermé 06 Juin 8:00AM

Radiopharm Theranostics Limited (RAD) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,02
( 5,26% )
Prix Achat
0,02
Prix Vente
0,021
Volume échangé
4 679 285
0,019 Fourchette du Jour 0,0205
0,017 Plage de 52 semaines 0,04
Cap du marché
Clôture Veille
0,019
Ouverture
0,02
Dernière Transaction
200000
@
0.02
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
AUD 2 733 824
Actions en circulation
3 544 216 160
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,05
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess (LTM)
16,28M
Bénéfice net (LTM)
-46,58M

À propos de Radiopharm Theranostics Limited

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Carlton, Australia
Fondé
2026
Radiopharm Theranostics Limited est coté dans le secteur Healthcare de la Australian Stock Exchange avec le ticker RAD. Le dernier cours de clôture d'Radiopharm Theranostics était de AUD0,02. Au cours de la dernière année, les actions de Radiopharm Theranostics ont été négociées dans une fourchette de prix de AUD 0,017 à AUD 0,04.

Radiopharm Theranostics compte actuellement 3 544 216 160 actions en circulation. La capitalisation boursière d'Radiopharm Theranostics est de AUD70,88 million. Radiopharm Theranostics a un ratio cours/bénéfice (ratio PE) de -1.05.

RAD Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.020.0210.01918837270.0199163DE
40.00052.56410256410.01950.0220.01819367250.02005948DE
12-0.002-9.090909090910.0220.0240.01826267840.02033759DE
26-0.002-9.090909090910.0220.0370.01764701610.0246079DE
52-0.007-25.92592592590.0270.040.01754857450.02555819DE
156-0.115-85.18518518520.1350.1550.01738947870.02938402DE
260-0.45-95.74468085110.470.4950.01728149940.04561796DE

RAD - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Limited share price?
The current share price of Radiopharm Theranostics Limited is AUD 0,02
How many Radiopharm Theranostics Limited shares are in issue?
Radiopharm Theranostics Limited has 3 544 216 160 shares in issue
What is the market cap of Radiopharm Theranostics Limited?
The market capitalisation of Radiopharm Theranostics Limited is AUD 70,88M
What is the 1 year trading range for Radiopharm Theranostics Limited share price?
Radiopharm Theranostics Limited has traded in the range of AUD 0,017 to AUD 0,04 during the past year
What is the PE ratio of Radiopharm Theranostics Limited?
The price to earnings ratio of Radiopharm Theranostics Limited is -1,05
What is the cash to sales ratio of Radiopharm Theranostics Limited?
The cash to sales ratio of Radiopharm Theranostics Limited is 4,35
What is the registered address of Radiopharm Theranostics Limited?
The registered address for Radiopharm Theranostics Limited is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Limited website address?
The website address for Radiopharm Theranostics Limited is www.radiopharmtheranostics.com
Which industry sector does Radiopharm Theranostics Limited operate in?
Radiopharm Theranostics Limited operates in the Biotechnology & Life Sciences sector

RAD Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock